vs
Side-by-side financial comparison of Bunge Global (BG) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Bunge Global is the larger business by last-quarter revenue ($4.9B vs $397.6M, roughly 12.3× Guardian Pharmacy Services, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 1.9%, a 3.3% gap on every dollar of revenue.
Bunge Global SA (BUN-ghee) is a global agribusiness and food company, incorporated in Geneva, Switzerland and headquartered in St. Louis, Missouri, United States.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
BG vs GRDN — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $4.9B | $397.6M |
| Net Profit | $95.0M | $20.9M |
| Gross Margin | 20.7% | 21.5% |
| Operating Margin | 1.8% | 7.7% |
| Net Margin | 1.9% | 5.3% |
| Revenue YoY | 22.2% | — |
| Net Profit YoY | -84.2% | — |
| EPS (diluted) | $-0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9B | $397.6M | ||
| Q3 25 | $4.4B | $377.4M | ||
| Q2 25 | $4.0B | $344.3M | ||
| Q1 25 | $3.7B | $329.3M | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $3.9B | $314.4M | ||
| Q2 24 | $3.7B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $95.0M | $20.9M | ||
| Q3 25 | $166.0M | $9.8M | ||
| Q2 25 | $354.0M | $9.0M | ||
| Q1 25 | $201.0M | $9.4M | ||
| Q4 24 | $602.0M | — | ||
| Q3 24 | $221.0M | $-122.0M | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $244.0M | — |
| Q4 25 | 20.7% | 21.5% | ||
| Q3 25 | 24.3% | 19.8% | ||
| Q2 25 | 18.4% | 19.8% | ||
| Q1 25 | 16.3% | 19.5% | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 19.9% | 19.4% | ||
| Q2 24 | 17.8% | — | ||
| Q1 24 | 22.2% | — |
| Q4 25 | 1.8% | 7.7% | ||
| Q3 25 | 6.2% | 4.3% | ||
| Q2 25 | 12.3% | 3.7% | ||
| Q1 25 | 7.8% | 3.9% | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 8.3% | -33.3% | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 9.4% | — |
| Q4 25 | 1.9% | 5.3% | ||
| Q3 25 | 3.8% | 2.6% | ||
| Q2 25 | 8.8% | 2.6% | ||
| Q1 25 | 5.5% | 2.9% | ||
| Q4 24 | 15.0% | — | ||
| Q3 24 | 5.7% | -38.8% | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 6.2% | — |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $2.61 | — | ||
| Q1 25 | $1.48 | — | ||
| Q4 24 | $4.27 | — | ||
| Q3 24 | $1.56 | — | ||
| Q2 24 | $0.48 | — | ||
| Q1 24 | $1.68 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.0B | $65.6M |
| Total DebtLower is stronger | $10.2B | $0 |
| Stockholders' EquityBook value | $15.9B | $217.9M |
| Total Assets | $44.5B | $412.7M |
| Debt / EquityLower = less leverage | 0.64× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0B | $65.6M | ||
| Q3 25 | $3.2B | $36.5M | ||
| Q2 25 | $7.1B | $18.8M | ||
| Q1 25 | $3.9B | $14.0M | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | $3.0B | $37.2M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $3.1B | — |
| Q4 25 | $10.2B | $0 | ||
| Q3 25 | $11.1B | — | ||
| Q2 25 | $7.7B | — | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.4B | — | ||
| Q3 24 | $5.4B | $34.3M | ||
| Q2 24 | $4.1B | — | ||
| Q1 24 | $4.1B | — |
| Q4 25 | $15.9B | $217.9M | ||
| Q3 25 | $15.8B | $195.5M | ||
| Q2 25 | $10.9B | $179.7M | ||
| Q1 25 | $10.6B | $163.2M | ||
| Q4 24 | $9.9B | — | ||
| Q3 24 | $10.1B | $133.9M | ||
| Q2 24 | $10.0B | — | ||
| Q1 24 | $10.6B | — |
| Q4 25 | $44.5B | $412.7M | ||
| Q3 25 | $46.3B | $390.0M | ||
| Q2 25 | $31.2B | $356.3M | ||
| Q1 25 | $26.7B | $334.0M | ||
| Q4 24 | $24.9B | — | ||
| Q3 24 | $25.3B | $348.0M | ||
| Q2 24 | $24.4B | — | ||
| Q1 24 | $25.8B | — |
| Q4 25 | 0.64× | 0.00× | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.54× | 0.26× | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.39× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | $34.6M |
| Free Cash FlowOCF − Capex | $809.0M | — |
| FCF MarginFCF / Revenue | 16.6% | — |
| Capex IntensityCapex / Revenue | 11.0% | — |
| Cash ConversionOCF / Net Profit | 14.18× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-879.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $34.6M | ||
| Q3 25 | $854.0M | $28.2M | ||
| Q2 25 | $-1.1B | $19.9M | ||
| Q1 25 | $-285.0M | $17.6M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $-1.5B | — | ||
| Q1 24 | $994.0M | — |
| Q4 25 | $809.0M | — | ||
| Q3 25 | $385.0M | $24.2M | ||
| Q2 25 | $-1.5B | — | ||
| Q1 25 | $-595.0M | — | ||
| Q4 24 | $564.0M | — | ||
| Q3 24 | $973.0M | — | ||
| Q2 24 | $-1.8B | — | ||
| Q1 24 | $758.0M | — |
| Q4 25 | 16.6% | — | ||
| Q3 25 | 8.8% | 6.4% | ||
| Q2 25 | -36.8% | — | ||
| Q1 25 | -16.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | -47.4% | — | ||
| Q1 24 | 19.2% | — |
| Q4 25 | 11.0% | — | ||
| Q3 25 | 10.7% | 1.1% | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 8.0% | — | ||
| Q1 24 | 6.0% | — |
| Q4 25 | 14.18× | 1.65× | ||
| Q3 25 | 5.14× | 2.87× | ||
| Q2 25 | -3.03× | 2.21× | ||
| Q1 25 | -1.42× | 1.86× | ||
| Q4 24 | 1.75× | — | ||
| Q3 24 | 6.00× | — | ||
| Q2 24 | -21.06× | — | ||
| Q1 24 | 4.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BG
| Other Oilseeds Processing And Refining | $4.6B | 95% |
| Other | $251.0M | 5% |
| Other Products | $3.0M | 0% |
GRDN
Segment breakdown not available.
